Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

X4 Pharmaceuticals (XFOR) Tax Provisions (2020 - 2025)

Historic Tax Provisions for X4 Pharmaceuticals (XFOR) over the last 6 years, with Q3 2025 value amounting to -$30000.0.

  • X4 Pharmaceuticals' Tax Provisions fell 30000.0% to -$30000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $299000.0, marking a year-over-year increase of 25176.47%. This contributed to the annual value of $310000.0 for FY2024, which is 29743.59% up from last year.
  • Latest data reveals that X4 Pharmaceuticals reported Tax Provisions of -$30000.0 as of Q3 2025, which was down 30000.0% from $37000.0 recorded in Q2 2025.
  • In the past 5 years, X4 Pharmaceuticals' Tax Provisions ranged from a high of $258000.0 in Q4 2024 and a low of -$30000.0 during Q3 2025
  • In the last 5 years, X4 Pharmaceuticals' Tax Provisions had a median value of $15000.0 in 2023 and averaged $24947.4.
  • Its Tax Provisions has fluctuated over the past 5 years, first plummeted by 75000.0% in 2022, then surged by 68181.82% in 2024.
  • X4 Pharmaceuticals' Tax Provisions (Quarter) stood at $3000.0 in 2021, then surged by 366.67% to $14000.0 in 2022, then soared by 135.71% to $33000.0 in 2023, then soared by 681.82% to $258000.0 in 2024, then crashed by 111.63% to -$30000.0 in 2025.
  • Its Tax Provisions stands at -$30000.0 for Q3 2025, versus $37000.0 for Q2 2025 and $34000.0 for Q1 2025.